Literature DB >> 2225492

The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives.

W M Hague1, J Adams, C Rodda, C G Brook, R de Bruyn, D B Grant, H S Jacobs.   

Abstract

Seventy-seven female patients (36 adults and 41 children aged under 16 years) with congenital adrenal hyperplasia (CAH) were assessed using pelvic ultrasound, as well as with standard endocrine tests and HLA typing. Forty-six close female relatives were also tested for ovarian morphology using ultrasound after assessment of their heterozygous state using HLA typing. The association of CAH with ultrasonically detected polycystic ovaries (PCO) was confirmed in 30/36 (83%) adult patients, 4/10 (40%) postpubertal girls and 1/31 (3%) pre and peripubertal girls: in all, 35/46 (76%) postmenarcheal patients. Six out of nine (67%) pre-menopausal mothers of patients with PCO, and 8/10 (80%) sisters of patients with PCO also had PCO. The proportions of both CAH patients and heterozygote subjects with PCO were significantly greater than that found in a normal population (P less than 0.0001). The finding, however, of two homozygous non-CAH-affected adult sisters with PCO and, conversely, of 10 heterozygous adult relatives and of 12 postmenarcheal CAH patients with normal ovaries, indicates that the ovarian morphological change may be independent of the adrenal lesion.

Entities:  

Mesh:

Year:  1990        PMID: 2225492     DOI: 10.1111/j.1365-2265.1990.tb03887.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  41 in total

1.  Anogenital distance in newborn daughters of women with polycystic ovary syndrome indicates fetal testosterone exposure.

Authors:  E S Barrett; K M Hoeger; S Sathyanarayana; D H Abbott; J B Redmon; R H N Nguyen; S H Swan
Journal:  J Dev Orig Health Dis       Date:  2018-01-09       Impact factor: 2.401

2.  Female Offspring From Chronic Hyperandrogenemic Dams Exhibit Delayed Puberty and Impaired Ovarian Reserve.

Authors:  Zhiqiang Wang; Mingjie Shen; Ping Xue; Sara A DiVall; James Segars; Sheng Wu
Journal:  Endocrinology       Date:  2018-02-01       Impact factor: 4.736

Review 3.  Adrenal steroidogenesis and congenital adrenal hyperplasia.

Authors:  Adina F Turcu; Richard J Auchus
Journal:  Endocrinol Metab Clin North Am       Date:  2015-06       Impact factor: 4.741

Review 4.  Fetal programming of polycystic ovary syndrome.

Authors:  Esra Bahar Gur; Muammer Karadeniz; Guluzar Arzu Turan
Journal:  World J Diabetes       Date:  2015-07-10

Review 5.  Ovarian and Extra-Ovarian Mediators in the Development of Polycystic Ovary Syndrome.

Authors:  Muraly Puttabyatappa; Vasantha Padmanabhan
Journal:  J Mol Endocrinol       Date:  2018-10-16       Impact factor: 5.098

Review 6.  The role of TGF-β in polycystic ovary syndrome.

Authors:  Nazia Raja-Khan; Margrit Urbanek; Raymond J Rodgers; Richard S Legro
Journal:  Reprod Sci       Date:  2013-04-12       Impact factor: 3.060

Review 7.  Gestational Hyperandrogenism in Developmental Programming.

Authors:  Christopher Hakim; Vasantha Padmanabhan; Arpita K Vyas
Journal:  Endocrinology       Date:  2017-02-01       Impact factor: 4.736

8.  Prevalence of ovarian adrenal rest tumours and polycystic ovaries in females with congenital adrenal hyperplasia: results of ultrasonography and MR imaging.

Authors:  Nike M M L Stikkelbroeck; Ad R M M Hermus; Diana Schouten; Harold M Suliman; Gerrit J Jager; Didi D M Braat; Barto J Otten
Journal:  Eur Radiol       Date:  2004-08-18       Impact factor: 5.315

9.  Developmental androgen excess programs sympathetic tone and adipose tissue dysfunction and predisposes to a cardiometabolic syndrome in female mice.

Authors:  Kazunari Nohara; Rizwana S Waraich; Suhuan Liu; Mathieu Ferron; Aurélie Waget; Matthew S Meyers; Gérard Karsenty; Rémy Burcelin; Franck Mauvais-Jarvis
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-04-23       Impact factor: 4.310

10.  Long-Term Gynecological Outcomes in Women with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.

Authors:  T H Johannsen; C P L Ripa; E Carlsen; J Starup; O H Nielsen; M Schwartz; K T Drzewiecki; E L Mortensen; K M Main
Journal:  Int J Pediatr Endocrinol       Date:  2010-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.